IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response.
Sign Up to like & getrecommendations! Published in 2024 at "European journal of endocrinology"
DOI: 10.1093/ejendo/lvae065
Abstract: Serum insulin-like growth factor (IGF-I) is the primary biochemical measure of disease activity in patients with acromegaly, and 2014 Endocrine Society guidelines recommended normal age-adjusted serum IGF-I as the biochemical target of treatment. However, quantification… read more here.
Keywords: igf; treatment; reference ranges; igf uln ... See more keywords